Company
Headquarters: Paris, France
CEO: Ms. Sophie Boissard
€685.7 Million
EUR as of Jan. 1, 2025
US$713.5 Million
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Korian provides integrated health and care services for the elderly in France, Germany, Belgium, Italy, Spain, and the Netherlands. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers homecare and hospital-at-home services. As of December 31, 2020, it operated 1,000 facilities with 88,651 beds. Korian has a partnership with Aedifica to invests in new property development projects in the Netherlands. The company was formerly known as Korian-Medica S.A. and changed its name to Korian in July 2015. Korian was founded in 2001 and is headquartered in Paris, France.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Korian has the following listings and related stock indices.
Stock: FSX: KO2 wb_incandescent
Stock: Euronext: KORI wb_incandescent